ABSTRACT
Ischemic stroke can activate multiple transcription factors and cause inflammatory reactions, which involve pattern recognition receptors with immunostimulatory effects. Toll-like receptor 4 (TLR4) is one of the receptors related to innate immunity and several inflammatory reactions. The promising anti- inflammatory activity of salvianolic acid B (SAB) had been previously reported, but its effect on ischemic stroke remains unknown. An oxygen-glucose deprivation and reoxygenation (OGD/R) model in vitro and a middle cerebral artery occlusion (MCAO) model in vivo were used in this paper, and the results showned that SAB remarkably increased the viabilities of PC12 cells and primary cortical neurons after OGD/R injury and notably prevented cerebral ischemia/reperfusion (I/R) injury. SAB also significantly ameliorated NeuN release from primary cortical neurons. Further research indicated that the neuroprotection of SAB was completed through inhibiting the TLR4/MyD88/TRAF6 signaling pathway. The blocking of TLR4 by SAB also restrained NF-kB transcriptional activity and pro-inflammatory cytokine responses (IL-1β, IL-6, and TNF-α). These findings supply a new insight that will aid in clarifying the effect of SAB against cerebral I/R injury and provide the development of SAB as a potential candidate for treating ischemic stroke.
Similar content being viewed by others
REFERENCES
Eltzschig, H.K., and T. Eckle. 2011. Ischemia and reperfusion—from mechanism to translation. Nature Medicine 17(11): 1391–1401.
Flynn, R.W., R.S. MacWalter, and A.S. Doney. 2008. The cost of cerebral ischaemia. Neuropharmacology 55(3): 250–256.
Lu, C., T. Ha, X. Wang, L. Liu, X. Zhang, E.O. Kimbrough, Z. Sha, M. Guan, J. Schweitzer, J. Kalbfleisch, D. Williams, and C. Li. 2014. The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling. Journal of the American Heart Association 3(2): e000629.
Cuzzocrea, S., D.P. Riley, A.P. Caputi, and D. Salvemini. 2001. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacological Reviews 53(1): 135–159.
Iadecola, C., and J. Anrather. 2011. The immunology of stroke: from mechanisms to translation. Nature Medicine 17(7): 796–808.
Lu, X., L. Ma, L. Ruan, Y. Kong, H. Mou, Z. Zhang, Z. Wang, J.M. Wang, and Y. Le. 2010. Resveratrol differentially modulates inflammatory responses of microglia and astrocytes. Journal of Neuroinflammation 7: 46.
Marin-Prida, J., N. Pavon-Fuentes, A. Llopiz-Arzuaga, J.R. Fernandez-Masso, L. Delgado-Roche, Y. Mendoza-Mari, S.P. Santana, A. Cruz-Ramirez, C. Valenzuela-Silva, M. Nazabal-Galvez, A. Cintado-Benitez, G.L. Pardo-Andreu, N. Polentarutti, F. Riva, E. Penton-Arias, and G. Penton-Rol. 2013. Phycocyanobilin promotes PC12 cell survival and modulates immune and inflammatory genes and oxidative stress markers in acute cerebral hypoperfusion in rats. Toxicology and Applied Pharmacology 272(1): 49–60.
Eskes, C., L. Juillerat-Jeanneret, G. Leuba, P. Honegger, and F. Monnet-Tschudi. 2003. Involvement of microglia-neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin. Journal of Neuroscience Research 71(4): 583–590.
Hanke, M.L., and T. Kielian. 2011. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clinical Science (London) 121(9): 367–387.
Gao, Y., X. Fang, Y. Tong, Y. Liu, and B. Zhang. 2009. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomedicine and Pharmacotherapy 63(6): 442–450.
Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology 2(8): 675–680.
Wang, P.F., H. Fang, J. Chen, S. Lin, Y. Liu, X.Y. **ong, Y.C. Wang, R.P. **ong, F.L. Lv, J. Wang, and Q.W. Yang. 2014. Polyinosinic-polycytidylic acid has therapeutic effects against cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via TLR3. Journal of Immunology 192(10): 4783–4794.
Michelsen, K.S., M.H. Wong, P.K. Shah, W. Zhang, J. Yano, T.M. Doherty, S. Akira, T.B. Rajavashisth, and M. Arditi. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proceedings of the National Academy of Sciences of the United States of America 101(29): 10679–10684.
Cao, C.X., Q.W. Yang, F.L. Lv, J. Cui, H.B. Fu, and J.Z. Wang. 2007. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochemical and Biophysical Research Communications 353(2): 509–514.
Caso, J.R., J.M. Pradillo, O. Hurtado, J.C. Leza, M.A. Moro, and I. Lizasoain. 2008. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke 39(4): 1314–1320.
Ridder, D.A., and M. Schwaninger. 2009. NF-kappaB signaling in cerebral ischemia. Neuroscience 158(3): 995–1006.
Tao, X., X. Sun, L. Yin, X. Han, L. Xu, Y. Qi, Y. Xu, H. Li, Y. Lin, K. Liu, and J. Peng. 2015. Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition. Free Radical Biology and Medicine 84: 103–115.
Chen, Q., and Y. Zeng. 2000. Anisodamine protects against neuronal death following cerebral ischemia in gerbils. Chinese Medical Journal 113(7): 636–639.
Wu, X., J. Su, L. Chen, B. Ma, X. Gu, and L. Zhu. 2015. Ginkgolide B protects neurons from ischemic injury by inhibiting the expression of RTP801. Cellular and Molecular Neurobiology 35(7): 943–952.
Zhao, Q., M. Yang, Y. Deng, H. Yu, L. Wang, F. Teng, K. Cho, H. Ma, P. Wu, X. Li, W. Wu, X. Liu, F. Xu, B. Jiang, and D.A. Guo. 2015. The safety evaluation of SAB and ginsenoside Rg1 combination on mice. International Journal of Molecular Sciences 16(12): 29345–29356.
Zhao, Y., Y. Guo, and X. Gu. 2011. SAB, a potential chemopreventive agent, for head and neck squamous cell cancer. Journal of Oncology 2011: 534548.
Ma, L., Y.Q. Guan, and Z.D. Du. 2015. SAB down-regulates matrix metalloproteinase-9 activity and expression in tumor necrosis factor-alpha-induced human coronary artery endothelial cells. Chinese Medical Journal 128(19): 2658–2663.
Agrawal, M., V. Kumar, A.K. Singh, M.P. Kashyap, V.K. Khanna, M.A. Siddiqui, and A.B. Pant. 2013. Trans-Resveratrol protects ischemic PC12 Cells by inhibiting the hypoxia associated transcription factors and increasing the levels of antioxidant defense enzymes. ACS Chemical Neuroscience 4(2): 285–294.
Mitsios, N., J. Gaffney, P. Kumar, J. Krupinski, S. Kumar, and M. Slevin. 2006. Pathophysiology of acute ischaemic stroke: an analysis of common signalling mechanisms and identification of new molecular targets. Pathobiology 73(4): 159–175.
Kanzler, H., F.J. Barrat, E.M. Hessel, and R.L. Coffman. 2007. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature Medicine 13(5): 552–559.
Hyakkoku, K., J. Hamanaka, K. Tsuruma, M. Shimazawa, H. Tanaka, S. Uematsu, S. Akira, N. Inagaki, H. Nagai, and H. Hara. 2010. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171(1): 258–267.
Gupta, A., Z.A. Cooper, M.E. Tulapurkar, R. Potla, T. Maity, J.D. Hasday, and I.S. Singh. 2013. Toll-like receptor agonists and febrile range hyperthermia synergize to induce heat shock protein 70 expression and extracellular release. Journal of Biological Chemistry 288(4): 2756–2766.
Hou, S.T., and J.P. MacManus. 2002. Molecular mechanisms of cerebral ischemia-induced neuronal death. International Review of Cytology 221: 93–148.
Emre, U., K. Rantanen, and T. Tatlisumak. 2007. Antithrombotic treatment in the prevention of ischemic stroke. Current Drug Targets 8(7): 817–823.
Chiu, B.Y., C.P. Chang, J.W. Lin, J.S. Yu, W.P. Liu, Y.C. Hsu, and M.T. Lin. 2014. Beneficial effect of astragalosides on stroke condition using PC12 cells under oxygen glucose deprivation and reperfusion. Cellular and Molecular Neurobiology 34(6): 825–837.
Hillion, J.A., K. Takahashi, D. Maric, C. Ruetzler, J.L. Barker, and J.M. Hallenbeck. 2005. Development of an ischemic tolerance model in a PC12 cell line. Journal of Cerebral Blood Flow and Metabolism 25(2): 154–162.
Muzio, M., N. Polentarutti, D. Bosisio, M.K. Prahladan, and A. Mantovani. 2000. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. Journal of Leukocyte Biology 67(4): 450–456.
Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. Journal of Immunology 162(7): 3749–3752.
Tsakiri, N., I. Kimber, N.J. Rothwell, and E. Pinteaux. 2008. Interleukin-1-induced interleukin-6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neurones. British Journal of Pharmacology 153(4): 775–783.
Li, B., J. Li, X. Pan, G. Ding, H. Cao, W. Jiang, J. Zheng, and H. Zhou. 2010. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation. International Immunopharmacology 10(3): 344–350.
Liu, T., T. Zhang, H. Yu, H. Shen, and W. **a. 2014. Adjudin protects against cerebral ischemia reperfusion injury by inhibition of neuroinflammation and blood–brain barrier disruption. Journal of Neuroinflammation 11: 107.
**n, Q., B. Cheng, Y. Pan, H. Liu, C. Yang, J. Chen, and B. Bai. 2015. Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation. Peptides 63: 55–62.
Li, H., J. Hu, L. Ma, Z. Yuan, Y. Wang, X. Wang, D. **ng, F. Lei, and L. Du. 2010. Comprehensive study of baicalin down-regulating NOD2 receptor expression of neurons with oxygen-glucose deprivation in vitro and cerebral ischemia-reperfusion in vivo. European Journal of Pharmacology 649(1–3): 92–99.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing Financial Interests
The authors declare no competing financial interests.
Additional information
Yujue Wang and Guang Chen contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, Y., Chen, G., Yu, X. et al. Salvianolic Acid B Ameliorates Cerebral Ischemia/Reperfusion Injury Through Inhibiting TLR4/MyD88 Signaling Pathway. Inflammation 39, 1503–1513 (2016). https://doi.org/10.1007/s10753-016-0384-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-016-0384-5